SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021984
Filing Date
2023-05-15
Accepted
2023-05-15 08:20:52
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20230331.htm   iXBRL 10-Q 2419235
2 EX-10.1 sprb-ex10_1.htm EX-10.1 32913
3 EX-31.1 sprb-ex31_1.htm EX-31.1 21332
4 EX-31.2 sprb-ex31_2.htm EX-31.2 19688
5 EX-32.1 sprb-ex32_1.htm EX-32.1 10483
6 EX-32.2 sprb-ex32_2.htm EX-32.2 10666
  Complete submission text file 0000950170-23-021984.txt   7387334

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sprb-20230331_cal.xml EX-101.CAL 39933
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20230331_lab.xml EX-101.LAB 392070
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sprb-20230331_def.xml EX-101.DEF 147699
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20230331_pre.xml EX-101.PRE 267374
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20230331.xsd EX-101.SCH 47855
52 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20230331_htm.xml XML 1116040
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 23918586
SIC: 2834 Pharmaceutical Preparations